Vitalhub (TSE:VHI) Price Target Raised to C$14.00 at TD Securities

Vitalhub (TSE:VHI) had its price objective lifted by investment analysts at TD Securities from C$13.00 to C$14.00 in a research note issued to investors on Monday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. TD Securities’ price target points to a potential upside of 39.03% from the company’s previous close.

Several other research firms have also issued reports on VHI. Canaccord Genuity Group boosted their target price on shares of Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a report on Thursday, January 16th. Scotiabank set a C$14.00 price objective on shares of Vitalhub and gave the stock an “outperform” rating in a research report on Thursday, January 30th. Finally, Raymond James set a C$13.50 target price on Vitalhub and gave the company an “outperform” rating in a research report on Thursday, March 27th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of C$12.08.

Vitalhub Stock Performance

Vitalhub stock opened at C$10.07 on Monday. The firm has a 50 day moving average price of C$10.42 and a two-hundred day moving average price of C$10.37. Vitalhub has a 52-week low of C$5.80 and a 52-week high of C$12.09. The firm has a market cap of C$544.71 million, a price-to-earnings ratio of 163.78, a PEG ratio of 1.18 and a beta of 1.26.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.